SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-018256
Filing Date
2024-06-26
Accepted
2024-06-26 17:22:56
Documents
2
Period of Report
2024-06-21

Document Format Files

Seq Description Document Type Size
1 form3-06262024_090652.html 3  
1 form3-06262024_090652.xml 3 8899
2 ex24-06262024_090655.htm EX-24 5660
  Complete submission text file 0001415889-24-018256.txt   16046
Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Issuer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VOR BIOPHARMA INC. 100 CAMBRIDGEPARK DRIVE, SUITE 101 CAMBRIDGE MA 02140
Business Address
Quinlan Amy (Reporting) CIK: 0002027706 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39979 | Film No.: 241074576